Recent News
28 August 2018
Interrad Medical, Inc.
LGB has acted as the European placement agent in the $7.5 million offering of secured convertible notes by Interrad Medical, Inc. Read more
24 August 2018
Windmill Extrusions Limited
LGB has arranged an exit for investors in the company’s 2014 MBO. Read more
10 August 2018
Reward Finance Group Limited
LGB Corporate Finance has advised Reward Finance Group Limited on the extension of its wholesale debt funding line by £10 million. Read more
25 July 2018
How wealth managers need to up their game to attract more female investors
Simone Westerhuis, Director of LGB Investments, wrote an article for Wealth Briefing Magazine on how wealth managers can attract more Read more
23 July 2018
Benchmarking private banks' succession planning strategies
Simone Westerhuis, Director of LGB Investments, contributed to an article for on succession planning strategies of major private banks for UHNWs. Read more
12 July 2018
Medium Term Notes - Quarterly Update - Q3 2018
We have continued to expand the range of applications for MTN programmes in the last quarter. Read more
9 July 2018
Global Banking and Finance Review
In an article in the Global Banking and Finance Review, Simone Westerhuis of LGB Investments considers how wealth managers can meet the demands of millennial investors. Read more
2 June 2018
Finance Digest
Angus Grierson, Managing Director of LGB Corporate Finance, has written an article for Finance Digest in which he considers whether the deal corridor with the US or EU offers British companies the better scope the growth? Read more
30 May 2018
SRT Marine Systems plc
SRT (AIM: SRT), the global provider of maritime surveillance and vessel tracking systems, has raised £3 million through an institutional placing of shares and has refinanced £1.15 million of maturing loan notes. Read more
30 April 2018
Wealth and Finance International
Simone Westerhuis, Director of LGB Investments, has written an article for Wealth and Finance International on how investors can benefit from private debt investments. Read more
18 April 2018
Scancell Holdings plc
Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer, has raised £7.5 million through an institutional placing of shares. Read more
31 January 2018